JAK2 Inhibitors for Myelofibrosis: Why are They Effective in Patients with and Without JAK2V617F Mutation?

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|12|9|1098-1109

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.12, Iss.9, 2012-01, pp. : 1098-1109

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Absence of JAK2 V617F mutation in gastric cancers

By Woo Lee Jong   Hwa Soung Young   Young Kim Su   Woo Nam Suk   Sang Park Won   Young Lee Jung   Jin Yoo Nam   Hyung Lee Sug  

Acta Oncologica, Vol. 45, Iss. 2, 2006-03 ,pp. : 222-223

Informa Healthcare

Access to resources Recommend Favorite

Advantages of the quenching probe method over other PCR-based methods for detection of the JAK2 V617F mutation

By            

Oncology Letters, Vol. 4, Iss. 2, 2012-01 ,pp. : 205-208

Spandidos Publications

Access to resources Recommend Favorite

Detection of JAK2 V617F mutation increases the diagnosis of myeloproliferative neoplasms

By  

Oncology Letters, Vol. 9, Iss. 2, 2015-01 ,pp. : 735-738

Spandidos Publications

Access to resources Recommend Favorite

A case of polycythemia rubra vera transforming into chronic phase JAK2 V617F mutation-negative Philadelphia chromosome-positive chronic myelogenous leukemia

By Shimanovsky Alexei  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1567-1568

Informa Healthcare

Access to resources Recommend Favorite

JAK2 V617F detected in two Bcell chronic lymphocytic leukemia patients without coexisting Philadelphia chromosomenegative myeloproliferative neoplasms: A report of two cases

By      

Oncology Letters, Vol. 8, Iss. 2, 2014-01 ,pp. : 841-844

Spandidos Publications

Access to resources Recommend Favorite